IDEAYA Biosciences (IDYA) Net Income towards Common Stockholders (2020 - 2025)
Historic Net Income towards Common Stockholders for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to $108.5 million.
- IDEAYA Biosciences' Net Income towards Common Stockholders rose 26212.76% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.7 million, marking a year-over-year increase of 8412.22%. This contributed to the annual value of -$327.0 million for FY2024, which is 14323.25% down from last year.
- IDEAYA Biosciences' Net Income towards Common Stockholders amounted to $108.5 million in Q3 2025, which was up 26212.76% from -$144.1 million recorded in Q4 2024.
- IDEAYA Biosciences' Net Income towards Common Stockholders' 5-year high stood at $108.5 million during Q3 2025, with a 5-year trough of -$144.1 million in Q4 2024.
- Over the past 5 years, IDEAYA Biosciences' median Net Income towards Common Stockholders value was -$26.3 million (recorded in 2023), while the average stood at -$27.4 million.
- In the last 5 years, IDEAYA Biosciences' Net Income towards Common Stockholders tumbled by 517969.7% in 2023 and then surged by 26212.76% in 2025.
- IDEAYA Biosciences' Net Income towards Common Stockholders (Quarter) stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then plummeted by 243.87% to -$144.1 million in 2024, then surged by 175.24% to $108.5 million in 2025.
- Its last three reported values are $108.5 million in Q3 2025, -$144.1 million for Q4 2024, and -$66.9 million during Q3 2024.